aTyr Pharma Inc (NASDAQ:LIFE)

1.15
Delayed Data
As of Jun 22
 -0.02 / -1.71%
Today’s Change
0.80
Today|||52-Week Range
6.50
-67.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization174.0K152.0K161.0K184.0K
 
 
 
 
 
 
Operating ExpensesGross Income-174.0K-152.0K-161.0K-184.0K
 
 
 
 
 
General Expenses11.7M10.7M11.0M10.0M
 
 
 
 
 
Research And Development8.4M7.1M5.3M6.2M
 
 
 
 
 
Total Operating Expenses11.9M10.8M11.2M10.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.9M-10.8M-11.2M-10.2M
 
 
 
 
 
Other Expenses-231.0K-363.0K-274.0K-447.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.1M-11.2M-11.5M-10.7M
 
 
 
 
 
Net Income-12.1M-11.2M-11.5M-10.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.8M25.8M29.8M29.8M
 
 
 
 
 
Shares To Calculate EPS Diluted23.8M25.8M29.8M29.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.43-$0.39-$0.36
 
 
 
 
 
EPS Diluted-$0.51-$0.43-$0.39-$0.36